Previous 10 |
SALT LAKE CITY, Aug. 30, 2021 (GLOBE NEWSWIRE) -- Sera Prognostics Inc., The Pregnancy Company™ (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced financial res...
Study demonstrates positive impact of the company’s PreTRM ® test and treat strategy on improving neonatal healthcare NICU and total hospital length-of-stay in preemies reduced by more than 70% Faster rate of discharge from the NICU for spontaneous pret...
After a slow start to the month, the IPO market revved back to life with 13 IPOs coming to market this past week. SPAC activity picked up, with seven blank check IPOs raising $940 million. New filers continued to flood the IPO pipeline, with fourteen IPOs and nine SPACs submitting...
News, Short Squeeze, Breakout and More Instantly...
Sera Prognostics Inc. Company Name:
SERA Stock Symbol:
NASDAQ Market:
Sera Prognostics Inc. Website:
Sera Prognostics Announces Conference Call and Webcast of Second Quarter Fiscal Year 2024 Financial Results on August 7, 2024 PR Newswire SALT LAKE CITY , July 25, 2024 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company ® (NASDAQ: SERA)...
Sera Prognostics PreTRM® Test Prevention Strategy Demonstrates 18% Reduction in Severe Neonatal Morbidity and Mortality in Newly Published AVERT Trial PR Newswire Sera Prognostics Announces Publication of Positive AVERT PRETERM TRIAL Results in the International Peer-R...
2024-07-06 13:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...